A Clinical Guide for Assessment and Prescription of Exercise and Physical Activity in Cardiac Rehabilitation. A CSANZ Position Statement. Heart Lung Circ. 2023.

ACSM Guidelines for Exercise Testing and Prescription (11th Ed), 2021. Wolters Kluwer

Adsett J, Mudge A, Morris N, et al. Aquatic exercise training and stable heart failure: a systematic review and meta-analysis. Int J Cardiol 2015;186:22-28.

Adsett J, Mullins R, Hwang R, et al. Repeated six minute walk tests in patients with chronic heart failure: are they clinically necessary? Eur J Cardiovasc Prev Rehabil 2011;18:601-606.

Ageno W, Becattini C, Brighton T, et al. Cardiovascular risk factors and venous thromboembolism:  A meta-analysis.  Circulation. 2008; 117: 93-102.

Agusti AG, Sauleda J, Miralles C, et al. Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002;166:485-489.

Aldcroft S, Taylor F, Blackstock F, et al. Psychoeducational rehabilitation for health behaviour change in coronary artery disease: A systematic review of controlled trials. J Cardiopulm Rehabil Prev 2011;31:273-281.

American Association of Cardiovascular and Pulmonary Rehabilitation. Guidelines for Cardiac Rehabilitation and Secondary Prevention Programs 5th Edition With Web Resource. Champaign, IL: Human Kinetics. 2013.

American College of Cardiology Foundation, American Heart Association, Physician Consortium for Performance Improvement®. Heart failure performance measurement set. American College of Cardiology, American Heart Association and American Medical Association. Updated May15, 2012.

American College of Sports Medicine. ACSM's Guidelines for Exercise Testing and Prescription. 9th ed. Philadelphia, PA: Lippincott Williams & Wilkins. 2013.

American Heart Association. Classes of Heart Failure.

American Psychiatric Association. Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: American Psychiatric Press, 2013.

Anderson L, Sharp GA, Norton RJ, et al. Home-based versus centre-based cardiac rehabilitation. Cochrane Database of Systematic Reviews 2017, Issue 6. Art. No.: CD007130. DOI: 10.1002/14651858.CD007130.pub4

Angermann C, Gelbrich G, Störk S, et al. Effects of selective serotonin re-uptake inhibition on mortality, morbidity and mood in depressed heart failure patients. American College of Cardiology 2015 Scientific Sessions; March 16, 2015; San Diego, CA. Abstract 414-05.

Anker S, Sharma R. The syndrome of cardiac cachexia. Int J Cardiol 2002;85:51-66.

Anker S, Swan J, Volterrani M, et al. The influence of muscle mass, strength, fatigability and blood flow on exercise capacity in cachectic and non-cachectic patients with chronic heart failure. Eur Heart J 1997;18:259-269.

Arzt M, Bradley TD. Treatment of sleep apnea in heart failure. Am J Respir Crit Care Med 2006;173:1300–1308.

Asadi-Lari M, Rao A, Gray D. Health-related quality-of-life tools in heart failure. Expert Rev of Pharmacoeconomics Outcomes Res 2005;5:267-270.

Asghar O, Al-Sunni A, Khavandi K, et al. Diabetic cardiomyopathy. Clin Sci (Lond) 2009;116:741-760.

Atherton JJ, Sindone A, De Pasquale CG, et al. National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the management of heart failure 2018. Med J Aust. 2018

Australian Bureau of Statistics. 4102.0 - Australian Social Trends, June 2009. Health Literacy.

Australian Institute of Health and Welfare 2010. Australia’s health 2010. Australia’s health series no. 12. Cat. no. AUS 122. Canberra: AIHW.

Australian Medicines Handbook 2015. Adelaide: Australian Medicines Handbook Pty Ltd. 2015.

Australian Pharmaceutical Advisory Council (APAC). Guiding principles for medication management in the community. June 2006.

Australian pharmaceutical formulary and handbook. 23rd ed. Canberra: Pharmaceutical Society of Australia. 2015.